The efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy for the first line therapy of Helicobacter pylori

被引：0
|
作者：
Moon, B. S. [1 ]
Yi, S. W. [1 ]
Lim, H. C. [1 ]
Lee, Y. C. [2 ]
机构：
[1] Yonsei Univ, Yongin Severance Hosp, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Seoul, South Korea
来源：
HELICOBACTER | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.01
引用
收藏
页数：1
相关论文
共 50 条
  • [41] BISMUTH-CONTAINING QUADRUPLE THERAPY IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A FIRST REAL LIFE ITALIAN EXPERIENCE
    Tursi, A.
    Franceschi, M.
    De Bastiani, R.
    Elisei, W.
    Baldassarre, G.
    Ferronato, A.
    Grillo, S.
    Landi, S.
    Zamparella, M.
    Boscariolo, L.
    Picchio, M.
    Di Mario, F.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E142 - E142
  • [42] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori (vol 114, pg 437, 2019)
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (05): : 835 - 835
  • [43] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S880 - S880
  • [44] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S483 - S483
  • [45] HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
    Gisbert, Javier P.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (06) : 307 - 309
  • [46] Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China
    Wang, L.
    Lin, Z.
    Chen, S.
    Li, J.
    Chen, C.
    Huang, Z.
    Ye, B.
    Ding, J.
    Li, W.
    Wu, L.
    Jiang, Y.
    Meng, L.
    Du, Q.
    Si, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (06) : 391 - 395
  • [47] Efficacy of concomitant non-bismuth quadruple therapy or levofloxacin-containing triple therapy after bismuth containing quadruple therapy failure in clarithromycin-resistant Helicobacter Pylori
    Kim, S.
    Choi, C.
    Kang, D.
    Nam, H.
    Ryu, D.
    [J]. HELICOBACTER, 2016, 21 : 143 - 144
  • [48] 10-day Sequential Versus 10-day Bismuth-Containing Quadruple Therapy As Empirical First-Line Treatment for Helicobacter pylori: An Open Label Randomized Crossover Trial
    Liu, Sze Hang Kevin
    Seto, Wai-Kay
    Hung, Ivan F.
    Leung, Wai K.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S54 - S54
  • [49] Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains
    Muller, Nelly
    Amiot, Aurelien
    Le Thuaut, Aurelie
    Bastuji-Garin, Sylvie
    Deforges, Lionel
    Delchier, Jean-Charles
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (04) : 517 - 524
  • [50] Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication
    Ye, Jian Fang
    Hong, Jun Bo
    Zhu, Yin
    Xie, Yong
    Shu, Xu
    Luo, Ling Yu
    Xie, Chuan
    Zhu, Zhen Hua
    Lu, Nong Hua
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (12) : 704 - 708
12345